Sysmex (OTCMKTS:SSMXY) Shares Gap Down – Time to Sell?

Sysmex Corporation ADR (OTCMKTS:SSMXY – Get Free Report)’s share price gapped down before the market opened on Tuesday. The stock had previously closed at $11.91, but opened at $11.40. Sysmex shares last traded at $11.40, with a volume of 293 shares changing hands.

Wall Street Analyst Weigh In

Separately, Zacks Research upgraded shares of Sysmex from a “strong sell” rating to a “hold” rating in a research report on Tuesday, August 18th. One investment analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Sysmex has a consensus rating of “Hold”.

Check Out Our Latest Stock Report on SSMXY

Sysmex Price Performance

The stock has a market capitalization of $7.49 billion, a P/E ratio of 28.33 and a beta of 1.09. The company has a debt-to-equity ratio of 0.23, a quick ratio of 2.53 and a current ratio of 3.40. The firm has a 50-day moving average price of $11.45 and a 200 day moving average price of $9.76.

Sysmex (OTCMKTS:SSMXY – Get Free Report) last released its earnings results on Friday, August 7th. The company reported $0.09 earnings per share for the quarter, topping analysts’ consensus estimates of $0.07 by $0.02. The company had revenue of $825.85 million during the quarter, compared to the consensus estimate of $741.67 million. Sysmex had a return on equity of 8.01% and a net margin of 7.62%.Sysmex has set its FY 2026 guidance at 0.382-0.382 EPS. On average, analysts expect that Sysmex Corporation ADR will post 0.42 EPS for the current year.

About Sysmex

(Get Free Report)

Sysmex Corporation is a Japan-based healthcare technology company that develops, manufactures and sells diagnostic instruments, reagents and related information systems. Its products are primarily used in clinical laboratories, hospitals and other healthcare settings to support the analysis of blood, urine and other biological samples.

The company is best known for its hematology testing systems, including automated analyzers used to assess blood cell counts and related parameters. Its portfolio also includes products for hemostasis and coagulation testing, urinalysis, clinical chemistry, immunochemistry and flow cytometry, as well as laboratory information systems, maintenance and other support services.

Sysmex was established in 1968 and is headquartered in Kobe, Japan.

Featured Articles

Receive News & Ratings for Sysmex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sysmex and related companies with MarketBeat.com's FREE daily email newsletter.